Skip to main content
. 2013 Feb 21;18(3):301–307. doi: 10.1634/theoncologist.2012-0238

Figure 2.

Figure 2.

Treatments and outcomes in patients with available data (29 or 39) with an overall response rate to treatment of 79% (23 or 29).

No therapy other than removal of implant alone.

*One patient had no further treatment after CHOP, one had ESHAP and auto-SCT prior to death.

Abbreviations: auto-SCT, autologous stem cell transplant; CHOP, cyclophosphamide, doxorubicin, vincristine, and prednisolone; CR, complete response; ESHAP, etoposide, methylprednisolone, cytarabine, and cisplatin; iALCL, implant-associated anaplastic large cell lymphoma; XRT, radiation therapy.